These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 27736657)
1. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Brigo F; Bragazzi N; Nardone R; Trinka E Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657 [TBL] [Abstract][Full Text] [Related]
2. A comparison of four antiepileptic drugs in status epilepticus: experience from India. Misra UK; Kalita J Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955 [TBL] [Abstract][Full Text] [Related]
3. A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus. Brigo F; Igwe SC; Nardone R; Tezzon F; Bongiovanni LG; Trinka E Epileptic Disord; 2013 Sep; 15(3):314-23. PubMed ID: 23981687 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of intravenous levetiracetam in status epilepticus: A meta-analysis and systematic review. Chu SS; Wang HJ; Zhu LN; Xu D; Wang XP; Liu L Seizure; 2020 Jan; 74():49-55. PubMed ID: 31830677 [TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus phenytoin in management of status epilepticus. Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652 [TBL] [Abstract][Full Text] [Related]
6. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Levetiracetam vs. Phenytoin as Second Line Antiseizure Medication for Pediatric Convulsive Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Angurana SK; Suthar R J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34089322 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis. DeMott JM; Slocum GW; Gottlieb M; Peksa GD Epilepsy Behav; 2020 Oct; 111():107286. PubMed ID: 32707535 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. Sánchez Fernández I; Gaínza-Lein M; Lamb N; Loddenkemper T Neurology; 2019 May; 92(20):e2339-e2348. PubMed ID: 31068480 [TBL] [Abstract][Full Text] [Related]
10. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Alvarez V; Januel JM; Burnand B; Rossetti AO Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881 [TBL] [Abstract][Full Text] [Related]
11. IV Valproate in generalized convulsive status epilepticus: a systematic review. Brigo F; Storti M; Del Felice A; Fiaschi A; Bongiovanni LG Eur J Neurol; 2012 Sep; 19(9):1180-91. PubMed ID: 22182304 [TBL] [Abstract][Full Text] [Related]
12. Intravenous sodium valproate in status epilepticus: review and Meta-analysis. Liampas I; Siokas V; Brotis A; Zintzaras E; Stefanidis I; Dardiotis E Int J Neurosci; 2021 Jan; 131(1):70-84. PubMed ID: 32075481 [No Abstract] [Full Text] [Related]
13. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study. Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis. Yi ZM; Zhong XL; Wang ML; Zhang Y; Zhai SD Front Pharmacol; 2020; 11():751. PubMed ID: 32670054 [TBL] [Abstract][Full Text] [Related]
15. A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus. Brigo F; Bragazzi NL; Lattanzi S; Nardone R; Trinka E Eur J Neurol; 2018 Mar; 25(3):451-463. PubMed ID: 29288520 [TBL] [Abstract][Full Text] [Related]
16. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism. Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065 [TBL] [Abstract][Full Text] [Related]
17. Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis. Brigo F; Del Giovane C; Nardone R; Trinka E; Lattanzi S Epilepsy Behav; 2019 Dec; 101(Pt B):106466. PubMed ID: 31462385 [TBL] [Abstract][Full Text] [Related]
18. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. van Vliet EA; Edelbroek PM; Gorter JA Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045 [TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus. Liu X; Wu Y; Chen Z; Ma M; Su L Int J Neurosci; 2012 Jun; 122(6):277-83. PubMed ID: 22248033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]